Leadership Overview
Genentech has 10 executives leading key functions including strategy, operations, marketing, and research.
Driven by a commitment to patient well-being, Genentech pioneers groundbreaking biopharmaceuticals, advancing medical science to address critical health challenges and improve global patient outcomes.
Driven by a commitment to patient well-being, Genentech pioneers groundbreaking biopharmaceuticals, advancing medical science to address critical health challenges and improve global patient outcomes.
Leadership Roles at Genentech
Ashley Magargee - Chief Executive Officer
Ashley Magargee, the Chief Executive Officer at Genentech, directs the company's overarching strategy and operational execution. Magargee guides the organization's focus on developing innovative therapies for serious medical conditions, aligning research and development efforts with market needs. This leadership role involves fostering a culture of scientific excellence and ensuring the company's biopharmaceutical advancements translate into tangible patient benefits. Magargee oversees critical functions that drive the company's mission to improve patient outcomes across the healthcare sector. The Chief Executive Officer ensures strategic partnerships and resource allocation support Genentech's long-term growth and impact in the biotechnology field. Ashley Magargee's direction is pivotal in navigating the complex landscape of drug discovery and commercialization, solidifying Genentech's position as a leader in biopharmaceutical innovation.
Scott Peng - Chief Operating Officer
Scott Peng, the Chief Operating Officer at Genentech, manages the company's day-to-day operations and ensures efficient resource allocation. Peng oversees the complex processes involved in biopharmaceutical development and manufacturing, supporting Genentech's mission to deliver innovative therapies for serious medical conditions. This leadership position involves optimizing supply chains, enhancing operational scalability, and maintaining high standards of quality and compliance. The Chief Operating Officer works closely with research and development teams to facilitate the transition of scientific discoveries into viable treatments. Scott Peng's focus on operational excellence is crucial for improving patient outcomes and ensuring the reliable delivery of Genentech's life-changing medicines. Peng drives initiatives that enhance productivity and support the company's strategic growth objectives.
Zoe Harris - Chief Marketing Officer
Zoe Harris, the Chief Marketing Officer at Genentech, spearheads all marketing initiatives and brand strategy. Harris directs the communication of Genentech's innovative therapies to healthcare professionals and patient communities, emphasizing the company's commitment to improving patient outcomes. This role involves translating complex scientific advancements into accessible messaging that highlights the value of biopharmaceutical development. The Chief Marketing Officer oversees market analysis, campaign development, and digital engagement strategies to ensure Genentech's therapies reach those in need. Harris collaborates with research and commercial teams to align marketing efforts with product lifecycles and therapeutic area focuses. Zoe Harris's leadership ensures that Genentech's groundbreaking work in serious medical conditions is effectively communicated, driving market adoption and patient access to life-changing treatments.
Cynthia Shafer - Chief of Staff
Cynthia Shafer, the Chief of Staff at Genentech, provides strategic support and operational oversight to executive leadership. Shafer facilitates the execution of key initiatives, ensuring alignment across departments and driving efficiency in complex projects. This role involves managing cross-functional communication, optimizing workflows, and supporting the strategic direction set by the Chief Executive Officer. The Chief of Staff acts as a key liaison, coordinating efforts to advance Genentech's mission of developing innovative therapies for serious medical conditions. Shafer's responsibilities include streamlining decision-making processes and ensuring that operational activities directly contribute to improving patient outcomes. Cynthia Shafer's expertise is critical in enhancing organizational effectiveness and supporting the company's research and development endeavors in the biopharmaceutical sector.
Beatriz Cansino - Director and Chief of Staff US Medical - Oncology Hematology
Beatriz Cansino, the Director and Chief of Staff US Medical - Oncology Hematology at Genentech, directs strategic operations within the oncology and hematology medical affairs division. Cansino ensures seamless execution of medical strategies, supporting the development and delivery of innovative therapies for these critical disease areas. This role involves close collaboration with clinical teams, research scientists, and commercial partners to advance patient care. The Director and Chief of Staff US Medical - Oncology Hematology oversees key projects aimed at improving patient outcomes through cutting-edge biopharmaceutical solutions. Cansino's leadership facilitates effective communication and operational alignment, ensuring that Genentech's advancements in oncology and hematology reach patients who need them most. Beatriz Cansino's contributions are vital to reinforcing Genentech's commitment to tackling serious medical conditions.
Sneha Villivalam - Senior Business Manager & Global To Head of Translational Medicine Omni Chief of Staff
Sneha Villivalam, the Senior Business Manager & Global To Head of Translational Medicine Omni Chief of Staff at Genentech, drives strategic initiatives across translational medicine and business operations. Villivalam enhances the efficiency and effectiveness of global translational medicine efforts, supporting the development of novel biopharmaceuticals. This multifaceted role involves managing key projects, fostering cross-functional collaboration, and ensuring alignment with Genentech's broader mission to address serious medical conditions. The Senior Business Manager & Global To Head of Translational Medicine Omni Chief of Staff provides critical operational support to leadership, facilitating the advancement of research from discovery to clinical application. Sneha Villivalam's expertise is instrumental in optimizing processes and accelerating the delivery of innovative therapies, ultimately aiming to improve patient outcomes.
Afsaneh Sahavi - Pharma Technical Operations Hillsboro Chief of Staff
Afsaneh Sahavi, the Pharma Technical Operations Hillsboro Chief of Staff at Genentech, oversees strategic operations within the Hillsboro technical operations facility. Sahavi ensures the efficient and compliant execution of pharmaceutical manufacturing processes, supporting Genentech's commitment to delivering high-quality biopharmaceuticals. This role involves optimizing operational workflows, managing key projects, and facilitating communication between technical teams and executive leadership. The Pharma Technical Operations Hillsboro Chief of Staff plays a crucial part in maintaining the integrity and scalability of drug production, directly contributing to the company's ability to address serious medical conditions. Afsaneh Sahavi's leadership enhances operational effectiveness, ensuring that Genentech's therapies are produced reliably to improve patient outcomes.
Natasha Faville - Chief of Staff & Director, Operations & Administration, Solid Tumor Squad
Natasha Faville, the Chief of Staff & Director, Operations & Administration, Solid Tumor Squad at Genentech, directs operational and administrative functions for the solid tumor research group. Faville ensures that the squad's operations are streamlined and effective, supporting the rapid advancement of innovative therapies for solid tumors. This position involves managing resources, coordinating project timelines, and facilitating communication to accelerate research progress. The Chief of Staff & Director, Operations & Administration, Solid Tumor Squad provides critical support to scientific leadership, enabling a focused approach to tackling serious medical conditions. Natasha Faville's operational acumen is essential for optimizing the workflow of the solid tumor squad, contributing to Genentech's overall mission of improving patient outcomes through biopharmaceutical innovation.
Ankita Chitre - Head Chief Marketing Officer, Steriles, Quality (North America)
Ankita Chitre, the Head Chief Marketing Officer, Steriles, Quality (North America) at Genentech, leads marketing strategies for sterile products and quality assurance across North America. Chitre focuses on communicating the value and reliability of Genentech's sterile biopharmaceutical offerings to the market. This role involves ensuring that marketing efforts align with stringent quality standards and regulatory requirements. The Head Chief Marketing Officer, Steriles, Quality (North America) collaborates with quality control and manufacturing teams to highlight Genentech's commitment to product integrity. Ankita Chitre's leadership ensures that marketing messages accurately reflect the high standards maintained in producing therapies for serious medical conditions, thereby supporting improved patient outcomes.
Matthias Perczynski - Chief of Staff Personalized Health Care Ix Head of Strategy
Matthias Perczynski, the Chief of Staff Personalized Health Care Ix Head of Strategy at Genentech, directs strategic planning and operational execution for personalized healthcare initiatives. Perczynski guides the development and implementation of strategies that leverage data and advanced analytics to tailor medical treatments. This role involves fostering innovation and ensuring alignment across diverse teams focused on personalized medicine. The Chief of Staff Personalized Health Care Ix Head of Strategy plays a pivotal part in advancing Genentech's mission to develop targeted therapies for serious medical conditions. Matthias Perczynski's strategic vision and operational oversight are critical for enhancing patient outcomes through customized biopharmaceutical solutions.
Explore Leadership Teams in Business Services
Danaher Corporation operates across the biotechnology, life sciences, and diagnostics sectors, delivering integrated solutions that enable the development and manufacture of therapeutic products globally. The company designs and manufactures specialized equipment, consumables, and services that address complex challenges in drug development, laboratory analysis, and clinical diagnostics. Within biotechnology, Danaher provides comprehensive bioprocess technologies and manufacturing support systems that streamline the creation of therapeutics. This includes cell culture media development, chromatography resins, filtration technologies, and single-use hardware alongside design and installation services for complete manufacturing suites. The company also offers laboratory-scale protein purification tools, analytical instruments, and healthcare filtration solutions that serve manufacturers and research institutions. The life sciences division encompasses advanced analytical instrumentation including mass spectrometers, flow cytometry systems, genomics platforms, and microscopy solutions. Danaher supplies critical consumables such as antibodies, reagents, and protein products, along with industrial filtration systems and genomic medicine offerings including custom nucleic acid products and plasmid DNA. These capabilities operate under several established brands that serve research and industrial applications.
Company Leadership
SK
SB
WD
Founded in 1991, Myriad Genetics is an American molecular diagnostic company specializing in discovering and delivering tests across major diseases. Myriad Genetics is located in Utah.
Company Leadership JD
SS
YA
CenExel is a leading integrated, wholly owned, nationwide clinical research site network comprised of 18 Centers of Excellence in major metropolitan areas across the U. S. With 40+ years of experience, our Centers of Excellence deliver deep scientific expertise, premium data, operational efficiencies, and exceptional patient engagement to drive successful complex clinical trial outcomes. The world's most results-driven Pharma, Biotech, and Clinical Research Organizations trust our strategic approach and benefit from our collaboration and unified sites commitment to real world solutions.
Company Leadership
SC
TB
Founded in 1986, AmSpec is headquartered in Cranbury, New Jersey. They provide inspection and testing services to multiple sectors of the agricultural, oil and petrochemical industries.
Company Leadership
SD
DN
GO
Frequently Asked Questions Regarding Genentech Top Executives and Leadership Team
Unlock more people and company data
